Imeglimin is an oral anti-diabetic medication belonging to the glimin class, which functions by enhancing insulin sensitivity and reducing hepatic glucose production to manage type 2 diabetes mellitus.… Read more











Imeglimin is an oral anti-diabetic medication belonging to the glimin class, which functions by enhancing insulin sensitivity and reducing hepatic glucose production to manage type 2 diabetes mellitus. Our category includes high-quality reference standards of Imeglimin, alongside its related synthetic impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories during the development and manufacturing process, enabling precise impurity profiling, method validation, and rigorous quality control testing. By utilizing these characterized reference standards, researchers and analytical chemists can ensure regulatory compliance, identify unknown degradants, and support the accurate quantification of drug substances in complex matrices. This comprehensive selection provides the necessary tools for both stability studies and routine analysis of Imeglimin-based formulations.